Shionogi & Co. Ltd.

In News

Shionogi 4Q R&D Expenses Y40.5B Vs Y29.2B - Moomoo

Moomoo - May 12, 2026

Cefiderocol Fetroja Effectiveness Real World Analysis Bacterial Infections - Infectious Disease Special Edition

Infectious Disease Special Edition - May 13, 2026

Shionogi & Co: Record revenue and profit growth fueled by M&A, royalties, and new product launches - TradingView

TradingView - May 12, 2026

Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant - Fierce Pharma

Fierce Pharma - Apr 08, 2026

Shionogi Selected as a “DX Stock 2026”｜塩野義製薬 - Shionogi Inc.

Shionogi Inc. - Apr 10, 2026

Shionogi Outlines FY2025 Results, FY2026 Outlook and 2030 Strategy - TipRanks

TipRanks - May 12, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Shionogi Secures US Contract to Expand Antibiotic Manufacturing and Biothreat Preparedness - Contagion Live

Contagion Live - Apr 09, 2026

Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone) - Business Wire

Business Wire - Apr 01, 2026

Shionogi starts phase 2 clinical trial for Pompe Disease - PMLiVE

PMLiVE - Apr 21, 2026

Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava - Pharmaceutical Executive

Pharmaceutical Executive - Apr 02, 2026

Assessing Shionogi (TSE:4507) Valuation After Strong Nine‑Month Earnings And Share Price Momentum - Yahoo Finance

Yahoo Finance - Feb 04, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment